-
Jan 13, 2025 | 
dermatologytimes.com | Isabella Tan
The drive for inclusivity in clinical trials has never been more urgent.
-
Dec 1, 2024 | 
mdpi.com | Aarushi Parikh |Isabella Tan |Bernard Cohen |Sydney M. Wolfe
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Nov 21, 2024 | 
dermatologytimes.com | Isabella Tan
Although solar lentigines pose minimal health risks, their presence can significantly affect patients’ aesthetic concerns and, in turn, their overall quality of life.
-
Sep 12, 2024 | 
dermatologytimes.com | Isabella Tan
The pathogenesis of atopic dermatitis (AD) is multifactorial, involving genetic predisposition, immunologic dysregulation, and environmental triggers.1 For individuals residing in hurricane-prone regions, the environmental and psychosocial challenges associated with tropical weather can exacerbate AD, potentially leading to increased morbidity.2 “As a medical provider raised in Florida, I have seen my fair share of hurricanes, as well as the damage they can cause.
-
Jun 12, 2024 | 
dermatologytimes.com | Isabella Tan
June 12, 2024Dermatology TimesDermatology Times, June 2024 (Vol. 45. No. 06)Researchers hypothesize that skin contact with e-cigarette fluids can trigger an inflammatory response.
-
Apr 17, 2024 | 
dermatologytimes.com | Isabella Tan |Bernard Cohen
Dermatologic conditions often present diagnostic challenges due to overlapping clinical features. Among these, scabies and atopic dermatitis (AD) share similarities, leading to potential misdiagnosis and delayed treatment.1 Findings from a recent study shed light on distinguishing between these conditions, offering clinical insights for dermatologists.2Scabies, caused by Sarcoptes scabiei hominis, manifests as an intensely pruritic rash with characteristic burrows and papules.
-
Mar 30, 2024 | 
mdpi.com | Isabella Tan |Alicia Podwojniak |Bernard Cohen |Aarushi Parikh
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Mar 19, 2024 | 
dermatologytimes.com | Isabella Tan
The visible manifestations of vitiligo are well documented, yet recent advancements have shifted the focus toward understanding its profound impact on psychological well-being and overall quality of life.1 While prevalence rates vary across populations and have been increasing in recent years, this underscores the need for a more comprehensive clinical management approach.2 This approach may consider vitiligo’s ramifications beyond dermatological dimensions, potentially accounting for age,...
-
Jan 12, 2024 | 
dermatologytimes.com | Isabella Tan
January 12, 2024Dermatology TimesDermatology Times, January 2024 (Vol. 45. No. 01)This article will discuss insights from research studies and offer specialized guidance aimed at dermatologists in hopes of fostering patient adherence in acne management.
-
Nov 26, 2023 | 
dermatologytimes.com | Isabella Tan
Until recently, there was a lack of internationally agreed-upon guidelines for the treatment of vitiligo. Recently, a significant breakthrough was achieved when 42 international vitiligo experts and 4 patient representatives collaborated and developed a consensus management strategy for vitiligo.1 Their expert-based clinical practice recommendations encompass the latest evidence on topical and systemic therapies, phototherapies, interventional approaches, and innovative treatments.
